“…In addition, 2 clinical studies have been conducted to assess the safety of probiotics in small groups of specific immunocompromised patients (e.g. patients with HIV infection), and the findings of these studies support the safety of probiotics consumed by such groups [74–76] Immunocompromised treated with – ( Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum , LGG, L. johnsonii LA 1, VSL 3, L. plantarum 299V (liver transplant), S. boulardii (HIV) – Absence of toxicity were determined [77–79] previously likewise pregnant women – (LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii) Absence of toxicity [80], Inflammatory bowel disease – ( Lactobaccillus acidophilus LA-5, Lactobacillus delbrueckii subsp. bulgaricus LBY-27, Bifidobacterium animalis subsp.…”